With antimicrobial resistance (AMR) continuing to grow as a global threat, the United States Food and Drug Administration (FDA) recently announced it is granting cooperative agreement funds for 3 projects focused on the collection, analysis, and data reporting of antimicrobial use (AMU) in animals.

In September, the Reagan-Udall Foundation for the FDA released a report on three industry roundtables regarding the ruling. The participants in the invite-only roundtables called out three major areas of concern: awareness of the rules, labeling, and warehouse management capacity.

The FDA’s Food Traceability Rule hits in January 2026. And a recent report from the Reagan-Udall Foundation found that retailers, suppliers, and distributors have no idea how it works.

The FDA’s Center for Tobacco Products, or CTP, is responsible for reviewing these new products, but its process needs reform. According to a report from the Reagan-Udall Foundation, the CTP’s lack of transparency and communication has created significant challenges for companies attempting to navigate the regulatory landscape.